UNITED STATES (OBSERVATORY NEWS) — A drug widely used to fight HIV / AIDS has succeeded in stopping Zika infection, according to a recent US study.
The study was conducted by researchers at the Louis Katz School of Medicine at Temple University in the United States and published results in the journal Molecular Therapy.
The team investigated the effects of Rilpivirine, a drug that has been in place since 2012 to treat HIV infection, and whether it can be used as a drug to treat Zika.
In experiments with animals infected with Zika virus and laboratory cells, the researchers discovered that the drug stopped the spread of Zika virus infection.
The team added that the drug works by targeting the enzymes on which AIDS and Zika depend on the spread, which are found in other viruses closely related to Zika, including viruses that cause dengue and fever. Bile “,” West Nile fever “and “hepatitis C”.
According to the study, existing drugs that treat diseases can be adapted to stop the recurrence of different viruses, and this will greatly accelerate the treatment of various infectious diseases.
Such a strategy would prevent thousands of deaths each year from diseases such as dengue, Ebola and Zika, the team said.
Dr. Kamel Khalili, the team’s lead researcher, said the study revealed that Rilpeverin prevents the recurrence of the Zika virus by preventing viral reproduction. This opens the way for us to be able to treat the virus easily.
“We now have a clear path and a starting point from which we can find ways to make these drugs more effective against viral diseases.”
According to previous studies, the Zika virus poses a serious risk to the health of the fetuses, and warned that pregnant women and fetuses in the stomachs of their mothers are more susceptible to infection with the virus “Zika” during the first and second trimester of pregnancy, because of the weakened immune system.
Studies have found evidence that Zika can cross the placental barrier, moving from mother to fetus during pregnancy, and can also leak into the brains of embryos in the uterus, blocking their growth and development, and causing a small head size.
The World Health Organization announced on February 1, 2017, that the spread of “Zika” is an emergency event in the world, pointing out that it may be linked to neurological disorders, including the small size of the head in the newborns and “Guillain-Barre” syndrome, which can cause paralysis.
The virus is mainly transmitted by mosquito bites, but scientists are studying any other possibilities, and Zika has associated thousands of births with birth defects.
World Health Organization (WHO) experts say deaths from the virus are rare, and most cases do not show any symptoms, but among the symptoms detected are moderate fever, eye inflammation, headache, joint pain and itchy skin.
This article is written and prepared by our foreign editors writing for OBSERVATORY NEWS from different countries around the world – material edited and published by OBSERVATORY staff in our newsroom.
OBSERVATORY — Breaking news source, real-time coverage of the world’s events, life, politics, money, business, finance, economy, markets, war and conflict zones.
Contact us: [email protected]
We are OBSERVATORY — the only funding and support we get from people – we are categorically not funded by any political party, any government somewhere or from any grouping that supports certain interests – the only support that makes OBSERVATORY possible came from you.